Pharmacodynamics of NPC-01( 1mg Norethisterone and 0.02mg Ethinyl Estradiol) and IKH-01( 1mg Norethisterone and 0.035mg Ethinyl Estradiol); Effect of NPC-01 and IKH-01 on Serum Concentrations of Estradiol, Progesterone, FSH and LH.
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2014
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Dysmenorrhoea
- Focus Pharmacodynamics
- Sponsors Nobelpharma
- 16 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2010 New trial record